Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1423053 MIAMI, FL
Back to AVBP Full portfolio

Position in AVBP

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$5,445,217
+$1,611,976 QoQ
Shares Held
156,742
-5.7% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 158 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Derivatives in AVBP

reported options exposure · as of Jun 30, 2026
CallValue
$2,834,784
CallShares
81,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,739,871 across 435 Biotechnology names. AVBP ranks #132 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in AVBP

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,834,784 81,600
2026-06-30 $5,445,217 156,742
2026-03-31 $595,206 25,800
2026-03-31 $3,721,191 161,300
2026-03-31 $3,833,241 166,157
2025-12-31 $9,225,060 458,502
2025-06-30 $732,669 33,655
2024-03-31 $5,117,103 286,512